Search Results

There are 32710 results for: content related to: Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance

  1. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

    Liver International

    Volume 25, Issue 3, June 2005, Pages: 472–489, Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata and for the Asian-Pacific consensus update working party on chronic hepatitis B

    Article first published online : 21 MAY 2005, DOI: 10.1111/j.1478-3231.2005.01134.x

  2. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration

    Liver International

    Volume 24, Issue 6, December 2004, Pages: 540–546, M. S. Dai, P. F. Wu, R. Y. Shyu, J. J. Lu and T. Y. Chao

    Article first published online : 26 NOV 2004, DOI: 10.1111/j.1478-3231.2004.0964.x

  3. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1169–1174, Taketoshi Suehiro, Mitsuo Shimada, Keiji Kishikawa, Tatsuo Shimura, Yuji Soejima, Tomoharu Yoshizumi, Kohji Hashimoto, Yasushi Mochida, Yoshihiko Maehara and Hiroyuki Kuwano

    Article first published online : 20 SEP 2005, DOI: 10.1111/j.1478-3231.2005.01165.x

  4. Lamivudine treatment for acute severe hepatitis B: a pilot study

    Liver International

    Volume 24, Issue 6, December 2004, Pages: 547–551, H. Schmilovitz-Weiss, Z. Ben-Ari, E. Sikuler, E. Zuckerman, W. Sbeit, Z. Ackerman, R. Safadi, Y. Lurie, G. Rosner, R. Tur-Kaspa and R. Reshef

    Article first published online : 26 NOV 2004, DOI: 10.1111/j.1478-3231.2004.0983.x

  5. Therapeutic implications of hepatitis B virus genotypes

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1097–1107, Chun-Jen Liu, Jia-Horng Kao and Ding-Shinn Chen

    Article first published online : 6 OCT 2005, DOI: 10.1111/j.1478-3231.2005.01177.x

  6. Lamivudine salts with improved solubilities

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 6, June 2012, Pages: 2143–2154, Felipe T. Martins, Rudy Bonfilio, Magali B. De Araújo and Javier Ellena

    Article first published online : 14 MAR 2012, DOI: 10.1002/jps.23117

  7. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Article first published online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  8. Hepatitis B virus-specific T cell response in chronic hepatitis B patients treated with lamivudine and interferon-α

    Liver International

    Volume 24, Issue 4, August 2004, Pages: 308–315, Oscar Pontesilli, Andeltje B. Van Nunen, Debby Van Riel, Patrizia Carotenuto, Hubert G. Niesters, Fons G. Uytdehaag, Robert A. De Man and Albert D. Osterhaus

    Article first published online : 2 JUL 2004, DOI: 10.1111/j.1478-3231.2004.0922.x

  9. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a

    Liver International

    Volume 24, Issue 2, April 2004, Pages: 98–104, Ingolf Schiefke, Chris Klecker, Melanie Maier, Ute Oesen, Gunnar Etzrodt, Andrea Tannapfel, Uwe G. Liebert and Frieder Berr

    Article first published online : 1 APR 2004, DOI: 10.1111/j.1478-3231.2004.0889.x

  10. Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 393–397, J. W. Shin, N. H. Park, J. H. Park, J. H. Park, I. D. Jeong, S-J. Bang, K. R. Joo and D. H. Kim

    Article first published online : 14 MAR 2005, DOI: 10.1111/j.1365-2893.2005.00606.x

  11. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Article first published online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  12. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Article first published online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  13. You have free access to this content
    Case Report of Lamivudine-Resistant Hepatitis B Virus Infection Post Liver Transplantation from a Hepatitis B Core Antibody Donor

    American Journal of Transplantation

    Volume 6, Issue 5p1, May 2006, Pages: 1077–1083, R. D. Yen, H. Bonatti, J. Mendez, J. Aranda-Michel, R. Satyanarayana and R. C. Dickson

    Article first published online : 5 APR 2006, DOI: 10.1111/j.1600-6143.2006.01313.x

  14. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation

    Intervention Review

    The Cochrane Library

    Lior H Katz, Ran Tur-Kaspa, Daniel G Guy and Mical Paul

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD006005.pub2

  15. You have free access to this content
    Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity

    Hepatology

    Volume 42, Issue 5, November 2005, Pages: 1028–1036, Eirini I. Rigopoulou, Deepak Suri, Shilpa Chokshi, Ivana Mullerova, Steven Rice, Richard S. Tedder, Roger Williams and Nikolai V. Naoumov

    Article first published online : 25 OCT 2005, DOI: 10.1002/hep.20888

  16. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Article first published online : 27 DEC 2007, DOI: 10.1002/hep.22106

  17. Developmental Pharmacokinetic Changes of Lamivudine in Infants and Children

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1824–1832, Dr Adriana H. Tremoulet, Dr Mina Nikanjam, Dr Tim R. Cressey, Dr Kulkanya Chokephaibulkit, Dr Ross McKinney, Dr Mark Mirochnick and Dr Edmund V. Capparelli

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011426563

  18. You have free access to this content
    Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing

    Clinical Microbiology and Infection

    Volume 18, Issue 10, October 2012, Pages: E404–E411, S.-Y. Ko, H.-B. Oh, C.-W. Park, H. C. Lee and J.-E. Lee

    Article first published online : 3 JUL 2012, DOI: 10.1111/j.1469-0691.2012.03951.x

  19. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Article first published online : 26 JAN 2007, DOI: 10.1002/hep.21513

  20. Lamivudine/Zidovudine as a Combined Formulation Tablet: Bioequivalence Compared with Lamivudine and Zidovudine Administered Concurrently and the Effect of Food on Absorption

    The Journal of Clinical Pharmacology

    Volume 39, Issue 6, June 1999, Pages: 593–605, Dr. Katy H. P. Moore, Ms. Shuching Shaw, Dr. Aziz L. Laurent, Ms. Peggy Lloyd, Mr. Benjamin Duncan, Mr. David M. Morris, Mr. Michael J. O'Mara and Dr. Gary E. Pakes

    Article first published online : 8 MAR 2013, DOI: 10.1177/00912709922008209